Proof of Usefulness Report

BigHat Biosciences

Analysis completed on 2/7/2026

+678
Proof of Usefulness Score
Category Standard

BigHat Biosciences is a verified, high-profile Series B biotechnology company with over $148M in funding and major partnerships (Amgen, BMS, Merck). The project possesses exceptional real-world utility and technical innovation in AI-driven antibody design. However, the submission itself contained significant inaccuracies (claiming 'most people have used my product', listing market cap as $17M, and exaggerating team size). The score reflects the high verified value of the entity, penalized slightly by the low quality of the provided evidence.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+225.0
Audience Reach Impact+64.0
Technical Innovation+171.0
Evidence Of Traction+180.0
Market Timing Relevance+95.0
Functional Completeness+2.5
Subtotal+737.5
Usefulness Multiplierx0.92
Final Score+679

Project Details

Project URL
bighatbio.com
Description
BigHat’s mission is to improve human health by making it far easier to design advanced, next-generation antibody therapeutics. Our AI-enabled experimental platform integrates a high-speed characterization or “wet” lab with machine learning technologies to speed the antibody engineering process. When applied, these design capabilities have the potential to drive the development of new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases. BigHat is backed by Section 32, Andreessen Horowitz, 8VC, Amgen Ventures, Bristol Myers Squibb, Quadrille, Grids Capital, AME Cloud Ventures, Innovation Endeavors and Gaingels.

Algorithm Insights

Market Position
Strong market validation with clear user adoption patterns
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline